Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis

Multiple Sclerosis Journal

Volumn 18, Issue 9, 2012, Pages 1229-1238

  Kumpfel T ^a   Gerdes, L A ^a   Wacker, T ^a,b   Blaschek, A ^b   Havla, J ^a   Krumbholz, M ^a   Pollmann W ^c   Feneberg, W ^c   Hohlfeld, R ^a   Lohse, P ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Marianne Strauss Hospital   (Germany)

Author keywords

FMF; MEFV gene; multiple sclerosis; susceptibility

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; EXON; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN FEVER GENE; MULTIPLE SCLEROSIS; PREVALENCE; SUBSTITUTION REACTION;

EID: 84866053051     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512437813     Document Type: Article

References (34)

1. Pras E, Aksentijevich I, Gruberg L, et al. Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med. 1992 ; 326: 1509-1513
2. A candidate gene for familial Mediterranean fever. Nat Genet. 1997 ; 17: 25-31
3. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997 ; 90: 797-807
4. Infevers database, available at: http://fmf.igh.cnrs.fr/infevers
5. Ben-Chetrit E, Touitou I. Familial Mediterranean fever in the world. Arthritis Rheum. 2009 ; 61: 1447-1453
6. Samuels J, Aksentijevich I, Torosyan Y, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine. 1999 ; 77: 268-297
7. Fragouli E, Eliopoulos E, Petraki E, et al. Familial Mediterranean Fever in Crete: a genetic and structural biological approach in a population of 'intermediate risk'. Clin Genet. 2008 ; 73: 152-159
8. Regina M, Nucera G, Diaco M, et al. Familial Mediterranean fever is no longer a rare disease in Italy. Eur J Hum Genet. 2003 ; 11: 50-56
9. Masters SL, Simon A, Aksentijevich I, et al. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol. 2009 ; 27: 621-668
10. Guz G, Kanbay M, Ozturk MA. Current perspectives on familial Mediterranean fever. Curr Opin Infect Dis. 2009 ; 22: 309-315
11. Dizdar O, Kalyoncu U, Karadag O, et al. Macrophage inflammatory protein-1alpha: a link between innate immunity and familial Mediterranean fever?. Cytokine. 2007 ; 37: 92-95
12. Akman-Demir G, Gul A, Gurol E, et al. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?. J Neurol. 2006 ; 253: 928-934
13. Shinar Y, Livneh A, Villa Y, et al. Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients. Genes Immun. 2003 ; 4: 197-203
14. Unal A, Dursun A, Emre U, et al. Evaluation of common mutations in the Mediterranean fever gene in Multiple Sclerosis patients: is it a susceptibility gene?. J Neurol Sci. 2010 ; 294: 38-42
15. Yahalom G, Kivity S, Lidar M, et al. Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts. Eur J Neurol. 2011 ; 18: 1146-1150
16. Kümpfel T, Hoffmann LA, Rübsamen H, et al. Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation. Arthritis Rheum. 2007 ; 56: 2774-2783
17. Blaschek A, Lohse P, Huss K, et al. Concurrent TNFRSF1A R92Q and pyrin E230K mutations in a child with multiple sclerosis. Mult Scler. 2010 ; 16: 1517-1520
18. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 ; 50: 121-127
19. Roxburgh RH, Seaman SR, Masterman T, et al. Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity. Neurology. 2005 ; 64: 1144-1151
20. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011 ; 476: 214-219
21. Kümpfel T, Hoffmann LA, Pellkofer H, et al. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases. Neurology. 2008 ; 71: 1812-1820
22. Kümpfel T, Hohlfeld R. TNFRS1A, TRAPS and multiple sclerosis. Nat Rev Neurol. 2009 ; 5: 528-529
23. De Jager PL, Jia X, Wang J, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet. 2009 ; 41: 776-782
24. Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol. 2005 ; 17: 586-599
25. Ben-Sasson SZ, Hu-Li J, Quiel J, et al. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc Natl Acad Sci. 2009 ; 106: 7119-7124
26. Gabay C, Lamacchia C, Palmer G. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol. 2010 ; 6: 232-241
27. Jha S, Srivastava SY, Brickey WJ, et al. The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J Neurosci. 2010 ; 30: 15811-15820
28. Gris D, Ye Z, Iocca HA, et al. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J Immunol. 2010 ; 185: 974-981
29. Tchernitchko D, Moutereau S, Legendre M, et al. MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients. Arthritis Rheum. 2005 ; 52: 3603-3605
30. Cañete JD, Arostegui JI, Queiró R, et al. An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism. Arthritis Rheum. 2007 ; 56: 2784-2788
31. Booth DR, Lachmann HJ, Gillmore JD, et al. Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148. QJM. 2001 ; 94: 527-31
32. Fonnesu C, Cerquaglia C, Giovinale M, et al. Familial Mediterranean Fever: a review for clinical management. Joint Bone Spine. 2009 ; 76: 227-233
33. Horrobin DF. Multiple sclerosis: the rational basis for treatment with colchicine and evening promrose oil. Med Hypotheses. 1979 ; 5: 365-378
34. Horrobin DF, Botez T, Botez MI. Polyunsaturated fatty acids and colchicine in multiple sclerosis. Br Med J. 1979 ; 1: 199-200